BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37297957)

  • 1. MELD-Na Alterations on the Liver Transplant Waiting List and Their Impact on Listing Outcome.
    Silberhumer GR; Györi G; Brugger J; Baumann L; Zehetmayer S; Soliman T; Berlakovich G
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study.
    Rodríguez-Perálvarez ML; Gómez-Orellana AM; Majumdar A; Bailey M; McCaughan GW; Gow P; Guerrero M; Taylor R; Guijo-Rubio D; Hervás-Martínez C; Tsochatzis EA
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):242-252. PubMed ID: 36528041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of changes of model for end-stage liver disease score during waiting time on post-liver transplant mortality.
    Al-Freah MA; Gane EJ; Livingstone V; McCall J; Munn S
    Hepatol Int; 2012 Apr; 6(2):491-7. PubMed ID: 21717197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation.
    Györi GP; Silberhumer GR; Zehetmayer S; Kern B; Hetz H; Soliman T; Steininger R; Mühlbacher F; Berlakovich GA
    Transpl Int; 2012 Sep; 25(9):935-40. PubMed ID: 22775308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
    BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.
    Salvalaggio P; Afonso RC; Pereira LA; Ferraz-Neto BH
    Einstein (Sao Paulo); 2012; 10(3):278-85. PubMed ID: 23386004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in liver transplantation before and after introduction of the MELD score.
    Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
    JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality while awaiting liver retransplantation: predictability of MELD scores.
    Watt KD; Menke T; Lyden E; McCashland TM
    Transplant Proc; 2005 Jun; 37(5):2172-3. PubMed ID: 15964370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
    Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK
    Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.
    Schmitt TM; Kumer SC; Shah N; Argo CK; Northup PG
    Ann Hepatol; 2010; 9(4):390-6. PubMed ID: 21057157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MELD upgrade exception: a successful strategy to optimize access to liver transplantation for patients with high waiting list mortality.
    Dirchwolf M; Becchetti C; Gschwend SG; Toso C; Dutkowski P; Immer F; Beyeler F; Rossi S; Schropp J; Dufour JF; Banz V;
    HPB (Oxford); 2022 Jul; 24(7):1168-1176. PubMed ID: 35065891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Center-related Bias in MELD Scores Within a Liver Transplant UNOS Region: A Call for Standardization.
    Verna EC; Connelly C; Dove LM; Adem P; Babic N; Corsetti J; Faix J; Hayden JA; Lifshitz M; Stotler B; Jin Z; Mohan S; Emond JC; Hod EA; Kratz A
    Transplantation; 2020 Jul; 104(7):1396-1402. PubMed ID: 31651793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.